Current knowledge and future research directions in treatment-related second primary malignancies

Currently, 17–19% of all new primary malignancies occur in survivors of cancer, causing substantial morbidity and mortality. Research has shown that cancer treatments are important contributors to second malignant neoplasm (SMN) risk. In this paper we summarise current knowledge with regard to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Lindsay M., Swerdlow, Anthony J., Schaapveld, Michael, Ramadan, Safaa, Hodgson, David C., Radford, John, van Leeuwen, Flora E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250537/
https://www.ncbi.nlm.nih.gov/pubmed/26217162
http://dx.doi.org/10.1016/j.ejcsup.2014.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250537/
https://www.ncbi.nlm.nih.gov/pubmed/26217162
http://dx.doi.org/10.1016/j.ejcsup.2014.05.001

Ejemplares similares